Payment completion for new share issuance and disposition of treasury stock under the overseas group employee Long-Term Incentive Plan. Reflects changes in issued shares and disposed shares; impact on future performance is expected to be minor.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4502","jir_company_name":"Takeda Pharmaceutical Company Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4502-20260708-01.pdf","jir_short_summary":"Payment completion for new share issuance and disposition of treasury stock under the overseas group employee Long-Term Incentive Plan. Reflects changes in issued shares and disposed shares; impact on future performance is expected to be minor.","jir_summary":"### Overview of changes\nThis reports the completion of payment for new share issuance and treasury stock disposition under the Long-Term Incentive Plan for overseas group employees, and the resulting change in issued shares. After the change, the number of newly issued shares is 10,892,917 shares, the number of disposed treasury shares is 6,096,159 shares, the total shares outstanding are 16,989,076, the issue price is \u00a55,050 per share, and the total amount is \u00a585,794,833,800.\n\n### Outlook and impact\nThe impact of this change on this year\u2019s results is expected to be minor, with the primary purpose limited to payments for employee compensation under the scheme and adjustments for rights and losses. Future IR disclosures may focus on the operation status of the plan and potential dilution effects.","jir_financial_highlights":"Newly issued shares: 16,989,076 \u682a (\u5909\u66f4\u5f8c\uff08\u4ee5\u524d: 16,877,109 \u682a\uff09)\nDisposal treasury stock: 6,096,159 \u682a (\u540c\u6570)\nIssue price: 1\u682a\u306b\u3064\u304d 5,050 \u5186 (\u5909\u66f4\u524d\u5f8c\u3068\u3082\u540c\u984d)\nTotal amount: 85,794,833,800 \u5186 (\u5909\u66f4\u5f8c)","jir_category":"","jir_hashtags":"#TakedaPharmaceutical, #Stock-based Compensation, #LongTermIncentive","jir_key_figures":"Newly issued shares: 10,892,917 shares\nDisposal treasury stock: 6,096,159 shares\nTotal shares: 16,989,076 shares\nIssue price: 5,050 yen\/\u682a\nTotal amount: 85,794,833,800 yen\nPayment date: 2026-07-08","jir_meta_title":"Takeda Pharmaceutical: Completion of Payment for New Share Issuance and Treasury Stock Disposition under Long-Term Incentive Plan | July 8, 2026","jir_meta_description":"Announcement of completion of payment for new share issuance and treasury stock disposition under Takeda Pharmaceutical's overseas group employee Long-Term Incentive Plan. Summary of issued shares, total amount, and payment date after the change.","jir_og_title":"Takeda Pharmaceutical Announces Completion of Payment for New Share Issuance and Treasury Stock Disposition","jir_og_description":"Payment completion for new share issuance and treasury stock disposition under the overseas group employee Long-Term Incentive Plan. Reports changes in total shares and total amount.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":884,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-77298","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n